Vascular access

International Journal of Artificial Organs

Volumn 25, Issue 5, 2002, Pages 347-353

  Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR ACCESS;

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; POLITEF; POLYETHERURETHAN; POLYMER; TICLOPIDINE;

ANGIOPLASTY; ARTERIOVENOUS FISTULA; ARTERY GRAFT; ARTERY OCCLUSION; BACTERIAL ENDOCARDITIS; BIODEGRADATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD CLOTTING DISORDER; BLOOD VESSEL GRAFT; CENTRAL VENOUS CATHETER; CIMINO BRESCIA FISTULA; COMORBIDITY; CONFERENCE PAPER; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DRUG EFFECT; GENETIC ENGINEERING; HEMODIALYSIS; HUMAN; HYPOTENSION; INFECTION; INFECTION RISK; INFECTIOUS COMPLICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEEDLE; PATIENT MONITORING; PATIENT REFERRAL; PRACTICE GUIDELINE; SAPHENOUS VEIN GRAFT; SCREENING TEST; SILVER IMPREGNATION; THROMBECTOMY; THROMBOSIS; UMBILICAL VEIN; UNITED STATES; VASCULAR ACCESS; VEIN BLOOD FLOW; VEIN OCCLUSION;

EID: 0036587340     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202500502     Document Type: Conference Paper

References (35)

1. Ifudu O, Mayers JD, Cohen LS, et al. Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. Am J Nephrol 1996; 16: 118-23.
2. Brescia MJ, Cimino JE, Appell K, Hurwich BJ, Scribner BH. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. 1966 (classical article). J Am Soc Nephrol 1999; 10: 193-9.
3. Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality (editorial). Perit Dial Int 2000; 20: 75-383.
4. Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist a European survey. Nephrol Dial Transplant 1999; 14 (suppl 6): S16-23.
5. Rodriguez JA, Armadans L, Ferrer E, et al. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15: 402-8.
6. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int 2000; 57: 639-45.
7. Woods JD, Turenne MN, Strawderman RL, et al. Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 1997; 30: 50-7.
8. Kapoian T, Sherman RA. A brief history of vascular access for hemodialysis: an unfinished story. Semin Nephrol 1997; 17: 239-45.
9. De Meester J, Vanholder R, De Roose J, Ringoir S. Factors and complications affecting catheter and technique survival with permanent single-lumen dialysis catheters. Nephrol Dial Transplant 1994; 9: 678-83.
10. Bogaert AM, Vanholder R, De Roose J, et al. Pseudo-Kaposi's sarcoma as a complication of Cimino-Brescia arteriovenous fistulas in hemodialysis patients. Nephron 1987; 46: 170-3.
11. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 1998; 98: 82-9.
12. Fan PY, Schwab SJ. Vascular access: concepts for the 1990s (editorial). J Am Soc Nephrol 1992; 3: 1-11.
13. May RE, Himmelfarb J, Yenicesu M, et al. Predictive measures of vascular access thrombosis: a prospective study. Kidney Int 1997; 52: 1656-62.
14. De Marchi S, Falleti E, Giacomello R, et al. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 1996; 7: 1169-77.
15. Hernandez E, Praga M, Alamo C, et al. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis. Nephron 1996; 72: 145-9.
16. Shemin D, Lapane, KL, Bausserman L, et al. Plasma total homocysteine and hemodialysis access thrombosis: a prospective study. J Am Soc Nephrol 1999; 10: 1095-9.
17. Sirrs S, Duncan L, Djurdjev O, et al. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 1999; 14: 738-43.
18. Manns BJ, Burgess ED, Parsons HG, et al. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular acccess thrombosis in hemodialysis patients. Kidney Int 1999; 55: 315-20.
19. Windus DW. Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993; 21: 457-71.
20. Allon M, Bailey R, Ballard R, et al. A multidisciplinary approach to hemodialysis access: prospective evaluation. Kidney Int 1998; 53: 473-9.
21. Roberts AB, Kahn MB, Bradford S, et al. Graft surveillance and angiosplasty prolongs dialysis graft patency. J Am Coll Surg 1996; 183: 486-92.
22. Besarab A, Lubkowski T, Frinak S, Ramanathan S, Escobar F. Detecting vascular access dysfunction. ASAIO J 1997; 43: M539-43.
23. Neyra NR, Ikizler TA, May RE, et al. Change in access blood flow over time predicts vascular access thrombosis. Kidney Int 1998; 54: 1714-9.
24. Krivitski NM. Theory and validation of access flow measurement by dilution technique during hemodialysis. Kidney Int 1995; 48: 244-50.
25. Gadallah MF, Paulson WD, Vickers B, Work J. Accuracy of Doppler ultrasound in diagnosing anatomic stenosis of hemodialysis arteriovenous access as compared with fistulography. Am J Kidney Dis 1998; 32: 273-7.
26. Himmelfarb J, Couper L, Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proleferation. Kidney Int 1997; 52: 1671-7.
27. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Antiplatelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int 1994; 45: 1477-83.
28. Harvey R, Bredenberg CE, Couper L, Himmelfarb J. Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Vasc Surg 1997; 25: 689-95.
29. Harter HR, Burch JW, Majerus PW, et al. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 1979; 301: 577-9.
30. Andrassy K, Malluche H, Bornefeld H, et al. Prevention of p.o clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double-blind study. Klin Wochenschr 1974; 52: 348-9.
31. Beathard GA. Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts. J Am Soc Nephrol 1995; 6: 1619-24.
32. Ayus JC, Sheikh-Hamad D. Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 1998; 9: 1314-7.
33. Robinson, DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 1997; 30: 521-4.
34. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catherer infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364-8.
35. Bambauer R, Mestres P, Schiel R, et al. Surface-treated large-bore catheters with silver-based coatings versus untreated catheters for extracorporeal detoxification methods. ASAIO J 1998; 44: 303-8.